WuXi Biologics to construct $60mn facility in Singapore

By Sophie Chapman
The Chinese pharmaceutical manufacturer, WuXi Biologics, has announced it will be expanding its operations to Singapore. The company has confirmed it...

The Chinese pharmaceutical manufacturer, WuXi Biologics, has announced it will be expanding its operations to Singapore.

The company has confirmed it’s third manufacturing site in less than a month, with a S$80mn (US$60mn) facility in its first Asian city country outside of China.

The contract development and manufacturing organisation (CDMO) aims for the site to employ 150 members of staff when operational.

The facility will feature 4,500l of bioreactor capacity, made up of two 2,000l traditional fed-batch reactors and one 500l perfusion-based continuous processing capabilities.

The site has been designed to manage clinical and small-volume commercial production.

SEE ALSO:

The project has been financial backed the Singapore Economic Development board, who will contribute to the funding.

“We are all very excited to initiate our first overseas Asian site in Singapore to enable local companies and expedite biologics development in Asia,” announced Dr Chris Chen, CEO of WuXi Biologics.

“We are committed to becoming the most comprehensive capability and technology platform in the global biologics industry to enable both local and global partners.”

WuXi Biologics has recently announced it will be developing a biologics facility in Dundalk, Ireland, costing €325mn ($392mn).

Share

Featured Articles

India’s smart manufacturing electric vehicle future

Indian IT service Panache Digilife has announced a manufacturing and supply chain agreement with electric vehicle manufacturer Revamp Moto

Manufacturing a legacy of safety, sustainability, and skill

Michael Vale, Group President for 3M’s safety & industrial business, explores diversity & environmental stewardship in manufacturing

5 minutes with: Simon Michie, Pulsant CTO

Simon Michie, CTO at Pulsant, explains why edge computing will transform manufacturing operations, but success will depend on having partnerships in place

Microsoft’s Çağlayan Arkan explores the supply chain

Procurement & Supply Chain

Elisabeth Brinton on the Microsoft Cloud for Sustainability

Technology

Aiimi’s Head of Solution Engineering Matt Eustace on risks

AI & Automation